Typical and atypical neuroleptics antagonize MK-801-induced locomotion and stereotypy in rats

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Neural Transmission / General Section JNT

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/BF01245347PMID 1358122
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice

  2005cited by this paper
• MK-801-induced stereotypy and its antagonism by neuroleptic drugs

  2005influential reference
• The selective dopamine D2 receptor antagonist raclopride discriminates between dopamine-mediated motor functions

  2004cited by this paper
• Intrastriatal injection of dl-2-amino-5-phosphonovaleric acid (AP-5) induces sniffing stereotypy that is antagonized by haloperidol and clozapine

  2004cited by this paper
• Mechanisms of action of atypical antipsychotic drugs. Implications for novel therapeutic strategies for schizophrenia.

  1991cited by this paper
• Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia.

  1991cited by this paper
• Animal models with construct validity for schizophrenia.

  1990cited by this paper
• NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus.

  1990cited by this paper
• The NMDA antagonist dizocilpine (MK-801) reverses haloperidol-induced movement initiation deficits.

  1990cited by this paper
• Non-competitive N-methyl-D-aspartate antagonists are potent activators of ventral tegmental A10 dopamine neurons.

  1990cited by this paper
• Neuroleptic-induced catalepsy as a model of Parkinson's disease II. Effect of glutamate antagonists

  1990cited by this paper
• Regulation of [3H]dopamine release from guinea pig striatum by NMDA receptor/channel activators and inhibitors.

  1990cited by this paper
• The glutamate-mediated release of dopamine in the rat striatum: further characterization of the dual excitatory-inhibitory function.

  1990cited by this paper
• Characterization of L-glutamate action on the release of endogenous dopamine from the rat caudate-putamen.

  1989cited by this paper
• Regulation of the mesocorticolimbic dopamine system by glutamic acid receptor subtypes.

  1989cited by this paper
• A "glutamatergic hypothesis" of schizophrenia. Rationale for pharmacotherapy with glycine.

  1989cited by this paper
• Hyperactivity induced by N-methyl-d-aspartate injections into nucleus accumbens: lack of evidence for mediation by dopaminergic neurons.

  1989cited by this paper
• The topography of MK-801-induced locomotor patterns in rats.

  1989cited by this paper
• Anticataleptic effects of the N-methyl-D-aspartate antagonist MK-801 in rats.

  1989cited by this paper
• In vivo demonstration of the enhancement of MK-801 by L-glutamate.

  1989cited by this paper
• MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys.

  1988cited by this paper
• Release-regulating D-2 dopamine receptors are located on striatal glutamatergic nerve terminals.

  1988cited by this paper
• Dopamine receptors and the dopamine hypothesis of schizophrenia

  1987cited by this paper
• New selective dopamine D-2 antagonists as antipsychotic agents. Pharmacological, chemical, structural and theoretical considerations.

  1987cited by this paper
• Unique behavioral effects of the NMDA antagonist, CPP, upon injection into the medial pre-frontal cortex of rats.

  1987cited by this paper
• Potential neuroleptic agents. 4. Chemistry, behavioral pharmacology, and inhibition of [3H]spiperone binding of 3,5-disubstituted N-[(1-ethyl-2-pyrrolidinyl)methyl]-6-methoxysalicylamides.

  1986cited by this paper
• Stereotyped behavior correlates better than ataxia with phencyclidine-receptor interactions.

  1986cited by this paper
• Presynaptic dopaminergic modulation of cortical input to the striatum.

  1986cited by this paper
• Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain.

  1984cited by this paper
• Atypical neuroleptics clozapine and thioridazine enhance amphetamine-induced stereotypy.

  1984cited by this paper
• Brain dopamine receptors.

  1980cited by this paper
• Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia.

  1980cited by this paper
• Phencyclidine-induced psychosis.

  1978cited by this paper
• Climbing behaviour induced by apomorphine in mice: a potential model for the detection of neuroleptic activity.

  1978cited by this paper
• Classification of neuroleptic drugs according to their ability to inhibit apomorphine-induced locomotion and gnawing: Evidence for two different mechanisms of action

  1978cited by this paper
• Detection of the neuroleptic properties of clozapine, sulpiride and thioridazine

  1975cited by this paper

• The Evolving Role of Animal Models in the Discovery and Development of Novel Treatments for Psychiatric Disorders.

  2023cites this paper
• MK801-induced locomotor activity in preweanling and adolescent male and female rats: role of the dopamine and serotonin systems

  2020cites this paper
• Melanin Concentrating Hormone Signaling Deficits in Schizophrenia: Association With Memory and Social Impairments and Abnormal Sensorimotor Gating

  2019cites this paper
• Neuro-behavioral effects after systemic administration of MK-801 and disinhibition of the anterior thalamic nucleus in rats: Potential relevance in schizophrenia.

  2019cites this paper
• Long-Term Effects of Juvenile NMDAr or DAr Antagonism on Adolescent Reward-Related Neurobehavioral Outcomes

  2019cites this paper
• Histamine H3 receptor antagonists display antischizophrenic activities in rats treated with MK-801

  2016cites this paper
• An emerging role of cGMP in the treatment of schizophrenia: A review.

  2016cites this paper
• Prediction error, ketamine and psychosis: An updated model

  2016cites this paper
• A Review of Oxytocin's Effects on the Positive, Negative, and Cognitive Domains of Schizophrenia.

  2016cites this paper
• Anti-schizophrenic activities of histamine H[sub]3[/sub] receptor antagonists in rats treated with MK-801

  2015cites this paper
• The Effect of Subchronic Dosing of Ciproxifan and Clobenpropit on Dopamine and Histamine Levels in Rats

  2015cites this paper
• A Methionine-Induced Animal Model of Schizophrenia: Face and Predictive Validity

  2015cites this paper
• Subchronic pharmacological and chronic genetic NMDA receptor hypofunction differentially regulate the Akt signaling pathway and Arc expression in juvenile and adult mice.

  2015influential citation
• Anti-schizophrenic activities of histamine H 3 receptor antagonists in rats treated with MK-801

  2015cites this paper
• Inducible Nitric Oxide Inhibitors Block NMDA Antagonist-Stimulated Motoric Behaviors and Medial Prefrontal Cortical Glutamate Efflux

  2015cites this paper
• Strain-dependent differential behavioral responses of zebrafish larvae to acute MK-801 treatment.

  2014cites this paper
• Synthesis, Characterisation, Molecular property prediction and Antipsychotic activity of Novel 6-fluoro-3-(piperidin-4-yl) benzo(d)isoxazole Derivatives

  2014cites this paper
• N-methyl-D-aspartate Receptors Are Involved in Caffeine-Induced Facilitation on Memory Retention of Passive Avoidance Learning in Rats

  2013cites this paper
• Paliperidone protects prefrontal cortical neurons from damages caused by MK-801 via Akt1/GSK3β signaling pathway.

  2013cites this paper
• Acute N-methyl-D-aspartate receptor hypofunction induced by MK801 evokes sex-specific changes in behaviors observed in open-field testing in adult male and proestrus female rats.

  2013cites this paper
• Long-lasting changes in hippocampal synaptic plasticity and cognition in an animal model of NMDA receptor dysfunction in psychosis.

  2013cites this paper
• The Glutamate Hypothesis of Schizophrenia Therapeutic Implications

  2012cites this paper
• Metabotropic glutamate receptors for new treatments in schizophrenia.

  2012cites this paper
• Local blockade of NMDA receptors in the rat prefrontal cortex increases c-Fos expression in multiple subcortical regions.

  2012cites this paper
• Cannabidiol and clozapine reverse MK-801-induced deficits in social interaction and hyperactivity in Sprague–Dawley rats

  2012cites this paper
• Acute NMDA Receptor Hypofunction induced by MK801 Evokes Sex-Specific Changes in Behaviors Observed in Open Field Testing in Adult Male and Proestrus Female Rats

  2012cites this paper
• Proteome analyses of cultured astrocytes treated with MK-801 and clozapine: similarities with schizophrenia

  2011cites this paper
• Effects of antipsychotics on the behavioral deficits in human dominant-negative DISC1 transgenic mice with neonatal polyI:C treatment.

  2011cites this paper
• Effect of cannabidiol in a MK-801-rodent model of aspects of schizophrenia.

  2011cites this paper
• 1-Methyl-1,2,3,4-tetrahydroisoquinoline Antagonizes a Rise in Brain Dopamine Metabolism, Glutamate Release in Frontal Cortex and Locomotor Hyperactivity Produced by MK-801 but not the Disruptions of Prepulse Inhibition, and Impairment of Working Memory in Rat

  2009cites this paper
• Combined administration of an mGlu2/3 receptor agonist and a 5-HT2A receptor antagonist markedly attenuate the psychomotor-activating and neurochemical effects of psychostimulants

  2009cites this paper
• Social memory in mice: disruption with an NMDA antagonist and attenuation with antipsychotic drugs.

  2009cites this paper
• A pharmacological MRI assessment of dizocilpine (MK-801) in the 3-nitroproprionic acid-lesioned rat.

  2008cites this paper
• A single application of MK801 causes symptoms of acute psychosis, deficits in spatial memory, and impairment of synaptic plasticity in rats

  2008influential citation
• Cannabinoids and the brain

  2008cites this paper
• Functional reactivity of the dopaminergic system following acute and chronic ketamine treatments

  2008cites this paper
• Rescue of hippocampal LTP and learning deficits in a rat model of psychosis by inhibition of glycine transporter‐1 (GlyT1)

  2008cites this paper
• Activities of the Antipsychotic Drugs Haloperidol and Risperidone on Behavioural Effects Induced by Ketamine in Mice

  2008cites this paper
• The Endocannabinoid System is a Major Player in Schizophrenia

  2008cites this paper
• Potentiation of the NMDA receptor in the treatment of schizophrenia: focused on the glycine site

  2007cites this paper
• Epinephrine potentiates antipsychotic, but not cataleptogenic effect of haloperidol in rats

  2007cites this paper
• Neurotransmitter receptor binding in the posterior cingulate cortex in schizophrenia and in the phencyclidine mouse model: an exploration of the NMDA hypofunction hypothesis of schizophrenia

  2007cites this paper
• From prediction error to psychosis: ketamine as a pharmacological model of delusions

  2007cites this paper
• Proteome analysis after co-administration of clozapine or haloperidol to MK-801-treated rats

  2007cites this paper
• Acute and long‐term effects of MK‐801 on direct cortical input evoked homosynaptic and heterosynaptic plasticity in the CA1 region of the female rat

  2007cites this paper
• Involvement of adenosine receptors in dizocilpine-induced motor activity in mice.

  2006cites this paper
• ADENOSINE RECEPTOR LIGANDS AND DIZOCILPINE-INDUCED ANTINOCICEPTION IN MICE

  2005cites this paper
• mGluR5, but not mGluR1, antagonist modifies MK-801-induced locomotor activity and deficit of prepulse inhibition.

  2005cites this paper
• The effects of haloperidol and clozapine on the disruption of sensorimotor gating induced by the noncompetitive glutamate antagonist MK-801

  2005cites this paper
• Effects of zotepine, haloperidol and clozapine on MK-801-induced stereotypy and locomotion in rats

  2005cites this paper
• Clozapine improves dizocilpine-induced delayed alternation impairment in rats

  2005cites this paper
• Effects of dopamine D1 and D2 receptor blockade on MK-801-induced hyperlocomotion in rats

  2005cites this paper
• Modulation of the locomotor activating effects of the noncompetitive NMDA receptor antagonist MK801 by dopamine D2/3 receptor agonists in mice.

  2004cites this paper
• Significance of dysfunctional glutamatergic transmission for the development of psychotic symptoms.

  2003cites this paper
• Effect of Riluzole on MK-801 and Amphetamine-Induced Hyperlocomotion

  2003cites this paper
• Chronic treatment with caffeine blunts the hyperlocomotor but not cognitive effects of the N-methyl-d-aspartate receptor antagonist MK-801 in mice

  2003cites this paper
• Evaluation of the efficacy of antipsychotic attenuation of phencyclidine-disrupted prepulse inhibition in rats

  2002cites this paper
• Effects of MK-801 and electroconvulsive shock on c-Fos expression in the rat hippocampus and frontal cortex.

  2002cites this paper
• Functional alteration by NMDA antagonist: Effects of L-Dopa, neuroleptics drug and postnatal administration

  2002cites this paper
• Integrative role for serotonergic and glutamatergic receptor mechanisms in the action of NMDA antagonists: potential relationships to antipsychotic drug actions on NMDA antagonist responsiveness.

  2002cites this paper
• Ketamine alters the availability of striatal dopamine transporter as measured by [(11)C]beta-CFT and [(11)C]beta-CIT-FE in the monkey brain.

  2001cites this paper
• Differential patterns of performance impairment result from changed reinforcer efficacy or distracting stimulation in a two-choice rodent spatial signal detection task.

  2001cites this paper
• Modulation of MK-801-induced behaviour by noradrenergic agents in mice

  2001cites this paper
• Combinations of clozapine and phencyclidine: effects on drug discrimination and behavioral inhibition in rats.

  2001cites this paper
• Dopamine D4 receptors and development of newer antipsychotic drugs

  2000cites this paper
• Atypical antipsychotic-like effect of AMPA receptor antagonists in the rat

  2000cites this paper
• Modulation of nociceptive transmission by NMDA/glycine site receptor in the ventroposterolateral nucleus of the thalamus

  2000cites this paper
• Antipsychotic-like effect of the AMPA receptor antagonist LY326325 as indicated by suppression of conditioned avoidance response in the rat

  1999cites this paper
• Mechanisms of typical and atypical antipsychotic drug action in relation to dopamine and NMDA receptor hypofunction hypotheses of schizophrenia

  1999cites this paper
• Comparison of brain metabolic activity patterns induced by ketamine, MK-801 and amphetamine in rats: support for NMDA receptor involvement in responses to subanesthetic dose of ketamine.

  1999cites this paper
• Does MK-801 discrimination constitute an animal model of schizophrenia useful for detecting atypical antipsychotics?

  1999cites this paper
• Effects of acute and chronic antidepressant administration on phencyclidine (PCP) induced locomotor hyperactivity.

  1999cites this paper
• Phencyclidine in the Social Interaction Test: An Animal Model of Schizophrenia with Face and Predictive Validity

  1999cites this paper
• Characterization of MK-801-induced behavior as a putative rat model of psychosis.

  1999cites this paper
• NMDA receptor antagonists inhibit apomorphine-induced climbing behavior not only in intact mice but also in reserpine-treated mice.

  1999cites this paper
• Preferential inhibition of dizocilpine-induced hyperlocomotion by olanzapine.

  1999cites this paper
• Effect of olanzapine on behavioural changes induced by FG 7142 and dizocilpine on active avoidance and plus maze tasks.

  1999cites this paper
• The locomotor effects of MK801 in the nucleus accumbens of developing and adult rats.

  1999cites this paper
• An integrated view of pathophysiological models of schizophrenia.

  1999cites this paper
• Atypical antipsychotic-like effects of the dopamine D3 receptor agonist, (+)-PD 128,907.

  1998cites this paper
• Levodopa neurotoxicity

  1998cites this paper
• Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications.

  1998cites this paper
• Effects of 5-hydroxytryptamine2 receptor antagonism on the behavioral activation and immediate early gene expression induced by dizocilpine.

  1998cites this paper
• Effects of dopamine agonists and antagonists on PCP-induced stereotyped behaviour and social isolation in the rat social interaction test

  1998cites this paper
• Haloperidol potentiates the EEG slowing of MK‐801 despite blocking its motor effects: implications for the PCP model of schizophrenia

  1998cites this paper
• Rodent data and general hypothesis: antipsychotic action exerted through 5-HT2A receptor antagonism is dependent on increased serotonergic tone

  1998cites this paper
• Effects of AMPA receptor antagonists on dopamine-mediated behaviors in mice

  1998cites this paper
• Lack of NMDA receptor involvement in caffeine-induced locomotor stimulation and tolerance in rats.

  1998cites this paper
• Differential effects of clozapine and haloperidol on ketamine-induced brain metabolic activation.

  1998cites this paper
• Focal ischemia enhances the adverse effect potential of N-methyl-D-aspartate receptor antagonists in rats.

  1998cites this paper
• MK-801-induced hyperlocomotion: differential effects of M100907, SDZ PSD 958 and raclopride.

  1997cites this paper
• Pharmacological characterization of MDL 105,519, an NMDA receptor glycine site antagonist.

  1997cites this paper
• A linkage study of the N‐methyl‐D‐aspartate receptor subunit gene loci and schizophrenia in southern African Bantu‐speaking families

  1997cites this paper
• Phencyclidine-induced deficits in prepulse inhibition of startle are blocked by prazosin, an alpha-1 noradrenergic antagonist.

  1997cites this paper
• Sensitization with clozapine: beyond the dopamine hypothesis.

  1997cites this paper
• Effects of AMPA receptor positive modulators on amphetamine- and dizocilpine-induced locomotion.

  1997cites this paper
• Interaction of the novel antipsychotic drug amperozide and its metabolite FG5620 with central nervous system receptors and monoamine uptake sites: relation to behavioral and clinical effects.

  1997cites this paper
• Behavioral pharmacology of N-methyl-D-aspartate antagonists: implications for the study and pharmacotherapy of anxiety and schizophrenia.

  1997cites this paper
• Effect of novel antipsychotic drugs on phencyclidine-induced stereotyped behaviour and social isolation in the rat social interaction test.

  1997cites this paper
• Mechanisms of action of atypical antipsychotic drugs: a critical analysis

  1996cites this paper